SEC Amends Disclosure Guidance on Options Related to Expiring Confidential Treatment Orders
March 10, 2021
The SEC’s Division of Corporation Finance has amended CF
Disclosure Guidance: Topic No. 7, Confidential Treatment Application
Submitted Pursuant to Rules 406 and 24b-2. The guidance
has been amended to give companies that previously obtained a confidential treatment
order three choices for how to handle the order that is about to expire. Those
choices are to (1) refile the unredacted exhibit, (2) extend the confidential period
in accordance with Rule 406 of the Securities Act or Rule 24b-2 of the Exchange Act,
or (3) transition to the rules governing the filing of redacted exhibits under
Regulation S-K, Item 601(b)(10)(iv), and parallel rules.